| 000 | 01759 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514215404.0 | ||
| 264 | 0 | _c20060831 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0172-8172 | ||
| 024 | 7 |
_a10.1007/s00296-004-0496-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTascioglu, Funda | |
| 245 | 0 | 0 |
_aThe treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin. _h[electronic resource] |
| 260 |
_bRheumatology international _cNov 2005 |
||
| 300 |
_a21-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAbsorptiometry, Photon |
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 |
_aAlendronate _xpharmacology |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
| 650 | 0 | 4 |
_aAmino Acids _xurine |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Resorption _xdrug therapy |
| 650 | 0 | 4 |
_aBone and Bones _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCalcitonin _xpharmacology |
| 650 | 0 | 4 | _aCalcium, Dietary |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteocalcin _xblood |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdrug therapy |
| 700 | 1 | _aColak, Omer | |
| 700 | 1 | _aArmagan, Onur | |
| 700 | 1 | _aAlatas, Ozkan | |
| 700 | 1 | _aOner, Cengiz | |
| 773 | 0 |
_tRheumatology international _gvol. 26 _gno. 1 _gp. 21-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00296-004-0496-3 _zAvailable from publisher's website |
| 999 |
_c15365291 _d15365291 |
||